XML 32 R3.htm IDEA: XBRL DOCUMENT
v3.25.1

Award Timing Disclosure | 12 Months Ended |
--- | --- | ---
Dec. 31, 2024 | Jan. 02, 2024 USD ($) shares $ / shares
Award Timing Disclosures [Line Items] |  |
Award Timing MNPI Disclosure | Timing of Equity Awards We generally grant equity awards to our employees in line with the following process. As part of the Company’s annual performance and compensation review process, at its regularly scheduled meeting in December, the Compensation and Leadership Development Committee approves preliminary target dollar values for grants of annual stock option, RSU and PRSU awards to our entire equity-eligible employee base, including our NEOs. At that same meeting, it sets a grant date for the annual awards (typically during the first week of January) and a valuation date (typically during the last week in December). Between the valuation date and the grant date, the Compensation and Leadership Development Committee approves final dollar values for each individual receiving a grant. In 2024, the annual grant date was January 2, 2024 and the number of shares subject to each approved option, RSU or PRSU award was determined by dividing the applicable dollar value by the closing price of our stock on the valuation date, December 28, 2023 (and for options, the Black-Scholes value on the same date). Outside of the annual equity award cycle, we may grant awards to employees in connection with a new hire, a promotion, or for other reasons. These grants generally occur on the fifteenth day of the relevant month. In addition, in 2023, we adopted an employee stock purchase plan; however, we have not yet commenced any offering periods under the plan. The Compensation and Leadership Development Committee does not grant equity awards in anticipation of the release of material nonpublic information and we do not time the release of material nonpublic information based on equity award grant dates. Option exercise price. The exercise price of a newly granted option is the closing price of the Company’s common stock on the Nasdaq stock market on the date of grant. As required by Item 402(x) of Regulation S-K under the Exchange Act, we are providing the following information about the stock options granted to our NEOs on January 2, 2024, within the period beginning four business days before we filed a Form 8-K reporting our preliminary 2023 revenue and 2024 strategic outlook, in advance of our presentation at the 42nd Annual J.P. Morgan Healthcare Conference.
| Name and Principal Position |  |  | Grant Date |  |  | Number of Securities Underlying the Award (#) |  |  | Exercise Price of the Award ($/Sh) |  |  | Grant Date Fair Value of the Award ($) |  |  | Percentage Change in the Closing Market Price of the Securities Underlying the Award Between the Trading Day Ending Immediately Prior to the Disclosure of Material Nonpublic Information and the Trading Day Beginning Immediately Following Disclosure of Material Nonpublic Information |
| Bradley L. Campbell President and Chief Executive Officer |  |  | 1/2/2024 |  |  | 265,517 |  |  | 14.24 |  |  | 2,105,627 |  |  | 1.0% |
| Simon Harford Chief Financial Officer |  |  | 1/2/2024 |  |  | 99,073 |  |  | 14.24 |  |  | 785,678 |  |  | 1.0% |
| Ellen S. Rosenberg Chief Legal Officer and Corporate Secretary |  |  | 1/2/2024 |  |  | 108,980 |  |  | 14.24 |  |  | 864,243 |  |  | 1.0% |
| David M. Clark Chief People Officer |  |  | 1/2/2024 |  |  | 83,221 |  |  | 14.24 |  |  | 659,967 |  |  | 1.0% |
| Jeffrey P. Castelli Chief Development Officer |  |  | 1/2/2024 |  |  | 99,073 |  |  | 14.24 |  |  | 785,678 |  |  | 1.0% |
Award Timing Method | We generally grant equity awards to our employees in line with the following process. As part of the Company’s annual performance and compensation review process, at its regularly scheduled meeting in December, the Compensation and Leadership Development Committee approves preliminary target dollar values for grants of annual stock option, RSU and PRSU awards to our entire equity-eligible employee base, including our NEOs. At that same meeting, it sets a grant date for the annual awards (typically during the first week of January) and a valuation date (typically during the last week in December). Between the valuation date and the grant date, the Compensation and Leadership Development Committee approves final dollar values for each individual receiving a grant. In 2024, the annual grant date was January 2, 2024 and the number of shares subject to each approved option, RSU or PRSU award was determined by dividing the applicable dollar value by the closing price of our stock on the valuation date, December 28, 2023 (and for options, the Black-Scholes value on the same date). Outside of the annual equity award cycle, we may grant awards to employees in connection with a new hire, a promotion, or for other reasons. These grants generally occur on the fifteenth day of the relevant month. In addition, in 2023, we adopted an employee stock purchase plan; however, we have not yet commenced any offering periods under the plan. |
Award Timing Predetermined | true |
Award Timing MNPI Considered | true |
Award Timing, How MNPI Considered | The Compensation and Leadership Development Committee does not grant equity awards in anticipation of the release of material nonpublic information and we do not time the release of material nonpublic information based on equity award grant dates. |
MNPI Disclosure Timed for Compensation Value | false |
Awards Close in Time to MNPI Disclosures, Table | Option exercise price. The exercise price of a newly granted option is the closing price of the Company’s common stock on the Nasdaq stock market on the date of grant. As required by Item 402(x) of Regulation S-K under the Exchange Act, we are providing the following information about the stock options granted to our NEOs on January 2, 2024, within the period beginning four business days before we filed a Form 8-K reporting our preliminary 2023 revenue and 2024 strategic outlook, in advance of our presentation at the 42nd Annual J.P. Morgan Healthcare Conference.
| Name and Principal Position |  |  | Grant Date |  |  | Number of Securities Underlying the Award (#) |  |  | Exercise Price of the Award ($/Sh) |  |  | Grant Date Fair Value of the Award ($) |  |  | Percentage Change in the Closing Market Price of the Securities Underlying the Award Between the Trading Day Ending Immediately Prior to the Disclosure of Material Nonpublic Information and the Trading Day Beginning Immediately Following Disclosure of Material Nonpublic Information |
| Bradley L. Campbell President and Chief Executive Officer |  |  | 1/2/2024 |  |  | 265,517 |  |  | 14.24 |  |  | 2,105,627 |  |  | 1.0% |
| Simon Harford Chief Financial Officer |  |  | 1/2/2024 |  |  | 99,073 |  |  | 14.24 |  |  | 785,678 |  |  | 1.0% |
| Ellen S. Rosenberg Chief Legal Officer and Corporate Secretary |  |  | 1/2/2024 |  |  | 108,980 |  |  | 14.24 |  |  | 864,243 |  |  | 1.0% |
| David M. Clark Chief People Officer |  |  | 1/2/2024 |  |  | 83,221 |  |  | 14.24 |  |  | 659,967 |  |  | 1.0% |
| Jeffrey P. Castelli Chief Development Officer |  |  | 1/2/2024 |  |  | 99,073 |  |  | 14.24 |  |  | 785,678 |  |  | 1.0% |
Bradley L. Campbell [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | Bradley L. Campbell
Underlying Securities | shares |  | 265,517
Exercise Price | $ / shares |  | $ 14.24
Fair Value as of Grant Date | $ |  | $ 2,105,627
Underlying Security Market Price Change |  | 0.01
Simon Harford [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | Simon Harford
Underlying Securities | shares |  | 99,073
Exercise Price | $ / shares |  | $ 14.24
Fair Value as of Grant Date | $ |  | $ 785,678
Underlying Security Market Price Change |  | 0.01
Ellen S. Rosenberg [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | Ellen S. Rosenberg
Underlying Securities | shares |  | 108,980
Exercise Price | $ / shares |  | $ 14.24
Fair Value as of Grant Date | $ |  | $ 864,243
Underlying Security Market Price Change |  | 0.01
David M. Clark [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | David M. Clark
Underlying Securities | shares |  | 83,221
Exercise Price | $ / shares |  | $ 14.24
Fair Value as of Grant Date | $ |  | $ 659,967
Underlying Security Market Price Change |  | 0.01
Jeffrey P. Castelli [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | Jeffrey P. Castelli
Underlying Securities | shares |  | 99,073
Exercise Price | $ / shares |  | $ 14.24
Fair Value as of Grant Date | $ |  | $ 785,678
Underlying Security Market Price Change |  | 0.01

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence D + Details
Name: | ecd_AwardExrcPrice
Namespace Prefix: | ecd_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence E + Details
Name: | ecd_AwardGrantDateFairValue
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgDiscLineItems
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgHowMnpiCnsdrdTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgMethodTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgMnpiCnsdrdFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgMnpiDiscTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgPredtrmndFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence C + Details
Name: | ecd_AwardUndrlygSecuritiesAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence A + Details
Name: | ecd_AwardsCloseToMnpiDiscIndName
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 + Details
Name: | ecd_AwardsCloseToMnpiDiscTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 + Details
Name: | ecd_AwardsCloseToMnpiDiscTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_MnpiDiscTimedForCompValFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence F + Details
Name: | ecd_UndrlygSecurityMktPriceChngPct
Namespace Prefix: | ecd_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ecd_IndividualAxis=fold_BradleyLCampbellMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=fold_SimonHarfordMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=fold_EllenSRosenbergMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=fold_DavidMClarkMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=fold_JeffreyPCastelliMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |